Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,307,253 shares of the medical equipment provider's stock after buying an additional 98,168 shares during the period. Deutsche Bank AG owned approximately 0.37% of Intuitive Surgical worth $682,334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after purchasing an additional 243,802 shares during the period. Fisher Asset Management LLC raised its holdings in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after buying an additional 86,488 shares during the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical in the fourth quarter worth $2,401,493,000. Finally, Invesco Ltd. increased its stake in Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock valued at $2,165,184,000 after buying an additional 295,025 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 0.9%

Intuitive Surgical stock traded up $4.99 during midday trading on Tuesday, hitting $566.42. 867,752 shares of the stock were exchanged, compared to its average volume of 1,630,375. Intuitive Surgical, Inc. has a 52-week low of $379.67 and a 52-week high of $616.00. The business's 50-day moving average price is $500.80 and its 200-day moving average price is $535.38. The stock has a market capitalization of $203.02 billion, a price-to-earnings ratio of 88.37, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the previous year, the business earned $1.50 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the sale, the executive vice president now owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,636 shares of company stock valued at $16,829,815 over the last ninety days. Insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on ISRG. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target for the company. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.